Strategic Roadmap and Financial Performance
Healthcare Platform | CMRC
Financial and Operational Review | Period Ended 31st March 2022
Revenue | AED MN (1)
24.9
1Q21
EBITDA | AED MN (1)
Financial Performance
72.1
1Q22
Significant year-on-year growth through inclusion of 3 months of result in 1Q-2022 vs. only one month
in the same period last year
• On a like-for-like basis net profit is in line with the prior year with overall revenue growth of 1%, offset
by post COVID cost normalization
Ramp-up of KSA Dharan facility continues with 70% occupancy delivered in March-2022 vs. 40% in
March-2021 moving the facility close to EBITDA breakeven for the full quarter
In the UAE, onsite expansion opportunity in Al Ain to add additional inpatient and outpatient capacity
underway, and new Abu Dhabi outpatient clinic under renovation
Net Cash / (Debt)
AED (302.8) MN (2)
31 Mar. 2022
✓ Completed Initiative
Ongoing Initiative
30.0%
22.0
Action Plan
32.0%
8.7
1Q21
1Q22
EBITDA Margin
Net Profit | AED MN (1) (3)
Corporate
Strategy
• Expand in UAE from existing base into Dubai and/or Northern Emirates
→ Al Ain facility onsite expansion to add additional 10+ inpatient beds and outpatient capacity
• Expand in KSA from existing base into a new facility in KSA (Eastern Province, Riyadh, Jeddah)
Launch new services (e.g., Sports Medicine, Orthopedic Surgery, Mental Health)
✓ Achieve Patient Satisfaction Score of 90%
22.0%
15.9
Corporate
Finance
Evaluate optimal capital structure and funding options for expansion plans
27.0%
6.7
Corporate
Governance
✓ Approve Delegation of Authority
✓ Develop financial and operational KPIs to track Management performance
1Q21
1Q22
Net Profit Margin
(1) 102021 includes the month of March only (2) Excluding third party lease liabilities of AED 76 MN (3) Excluding finance costs associated with acquisition finance
18View entire presentation